| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/19/2006 | CA2567680A1 Pharmaceutical composition comprising an ointment and two solubilized active principles |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615932A2 Podophhyllotoxin derivatives as igf-1r inhibitors |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615622A2 Once daily formulations of tetracyclines |
| 01/18/2006 | EP1470138B1 Mmp inhibitors |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1232183B1 Peptides having antiangiogenic activity |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1214064A4 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1723028A Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same |
| 01/18/2006 | CN1721004A Biological active antibiotic dressing |
| 01/18/2006 | CN1720989A Sustained release microsphere of epidermal growth factor, its preparation method and application |
| 01/18/2006 | CN1720981A Medicine for treating burn and scald |
| 01/18/2006 | CN1720972A Chinese medicine for treating dermatomycosis and its preparing process |
| 01/18/2006 | CN1720953A Method for preparing gene-caring weight-reducing medicine |
| 01/18/2006 | CN1720952A Process for heat-free extraction of fresh arnebia component |
| 01/18/2006 | CN1720925A Wart treating liquid |
| 01/18/2006 | CN1237176C Method for remodelling cell wall polysaccharide structures in plants |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236809C Trauma treating medicament and method for making same |
| 01/18/2006 | CN1236805C Wanpi ointment for treating skin disease |
| 01/18/2006 | CN1236801C Licorice root compound for preventing and treating acne |
| 01/18/2006 | CN1236797C External use Chinese medicinal ointment for treating burn and its preparation method |
| 01/18/2006 | CN1236794C Burn treating medicine |
| 01/18/2006 | CN1236789C Medicine for treating mycotic infection beriberi |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987109 Solubilized topoisomerase poison agents |
| 01/17/2006 | US6987102 Methods to mobilize progenitor/stem cells |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2177171C Novel substituted oxazolidines |
| 01/16/2006 | CA2512330A1 Use of legume products for the treatment and prevention of radiotherapy-induced skin damage |
| 01/12/2006 | WO2006003290A2 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 01/12/2006 | WO2004075816A3 Method for the production of flavonoid-containing compositions and use thereof |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009521 Lipoxin analogs as novel inhibitors of angiogenesis |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009494 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 01/12/2006 | US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/12/2006 | US20060009436 11 beta -Fluoro-7 alpha -{5-[methyl(7,7,8,8,9,9,9-heptafluorononyl)amino]pentyl}-17 alpha -methylestra-1,3,5(10)-triene-3,17 beta -diol N-oxide; antiestrogen compound whose metabolism can be controlled; alveolar macrophages do not build up; oral administration |
| 01/12/2006 | US20060009426 Pharmaceutical compositions comprising calcitriol and a clobetasol propionate |
| 01/12/2006 | US20060009422 Antibiotics incorporating borinic acid complexes; (bis(3-chloro-4-methylphenyl)boryloxy)(3-hydroxypyridin-2-yl)methanone; Antiinflammatory drugs; enhanced stability |
| 01/12/2006 | US20060009416 Vitamin B6, pyridinoline, 3-hydroxypyridine, or an N-alkyl-3-hydroxypyridine; sunscreen agents |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009385 Multiple-variable dose regimen for treating TNFalpha-related disorders |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060008436 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses |
| 01/12/2006 | CA2572119A1 Combination therapies utilizing benzamide inhibitors of the p2x7 receptor |
| 01/12/2006 | CA2570224A1 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 01/12/2006 | CA2570199A1 Use of highly sulfated polysaccharide derivatives of low molar mass for modulating angiogenesis |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/12/2006 | CA2568262A1 Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 01/12/2006 | CA2511786A1 Method for recommending an acne treatment/prevention program |
| 01/11/2006 | EP1614697A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614430A2 Compositions containing anti-acne agents and the use thereof |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1614414A2 Compositions comprising a copper compound for treatment of mammalian diseases |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613588A2 2-propylidene-19-nor-vitamin d compounds |
| 01/11/2006 | EP1613341A2 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| 01/11/2006 | EP1613336A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 01/11/2006 | EP1613330A1 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 01/11/2006 | EP1613317A1 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases |
| 01/11/2006 | EP1613295A1 Use of alkyl resorcinols in the treatment of acne |
| 01/11/2006 | EP1613294A2 Peptides and derivatives thereof as inhibitors of oxidative-induced degradation phenomena and compositions containing them |
| 01/11/2006 | EP1613278A1 A topical agent containing niacin for application to the skin prior to luminous treatment |
| 01/11/2006 | EP1581172A4 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
| 01/11/2006 | EP1485120B1 Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constituents, for externally treating open, in particular chronic wounds |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |